We use cookies and other technologies on this website to enhance your user experience.
By clicking any link on this page you are giving your consent to our Privacy Policy and Cookies Policy.
DR 2018 图标

1.0.1 by EyeDoctor DrJohn


2023年01月20日

关于DR 2018

研讨会糖尿病视网膜病变 - 1月6日至七日2018:Aravind眼科医院,马杜赖

Symposium on Diabetic Retinopathy - Jan 6-7, 2018 :Aravind Eye Hospital, Madurai

Aravind Eye Hospital is honoured to welcome you to its popular biennial 7th Symposium on Diabetic Retinopathy. This year it is being cohosted by the other 3 major eye institutes of South India - Sankara Nethralaya, LVPEI and Narayana Nethralaya.

In today's world, there are several exciting developments taking place rapidly in the management of diabetic retinopathy. There is a Paradigm shift in the management of retinopathy from Lasers to a whole gamut of Pharmacotherapy. You will be hearing directly from the very people doing the cutting edge research. The eminent faculty members from leading research centres in USA, UK & Singapore will share their views on current developments and future trends in this field. This meeting will focus onlyon diabetic retinopathy discussing from the basic of DR to the treatments that are out in the horizon.

With the advent of Pharmacotherapy, even the general ophthalmologists are treating DR and so it becomes all the more important for every ophthalmologist to learn all aspects of DR management.

We invite you to join us, in this prestigious symposium that promises to be stimulating and rewarding for all participants.

Dr. R. Kim

Organising Secretary - DR 2018

Chief - Retina Vitreous Services

Chief Medical Officer

Aravind Eye Hospital, Madurai

最新版本1.0.1更新日志

Last updated on 2023年01月20日

Sessions
Discussion
Faculty
Going to Madurai
Sightseeing
Contact us

翻译中...

更多应用信息

最新版本

请求 DR 2018 更新 1.0.1

上传者

Esa

系统要求

Android 2.1+

Available on

DR 2018 来源 Google Play

更多

DR 2018 屏幕截图

订阅APKPure
第一时间获取热门安卓游戏应用的首发体验,最新资讯和玩法教程。
不,谢谢
订阅
订阅成功!
您已订阅APKPure。
订阅APKPure
第一时间获取热门安卓游戏应用的首发体验,最新资讯和玩法教程。
不,谢谢
订阅
成功!
您已订阅我们的邮件通知。